(NASDAQ: BTMD) Biote's forecast annual revenue growth rate of 7.92% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Biote's revenue in 2025 is $199,379,000.On average, 5 Wall Street analysts forecast BTMD's revenue for 2025 to be $10,359,077,818, with the lowest BTMD revenue forecast at $10,221,508,811, and the highest BTMD revenue forecast at $10,477,109,799. On average, 5 Wall Street analysts forecast BTMD's revenue for 2026 to be $11,248,771,712, with the lowest BTMD revenue forecast at $10,936,685,437, and the highest BTMD revenue forecast at $11,894,303,395.
In 2027, BTMD is forecast to generate $12,954,161,749 in revenue, with the lowest revenue forecast at $12,596,826,506 and the highest revenue forecast at $13,311,496,991.